Results 281 to 290 of about 295,397 (306)
Some of the next articles are maybe not open access.

Lupus nephritis

Nature Reviews Disease Primers, 2020
Hans-Joachim Anders   +2 more
exaly   +2 more sources

Antibodies to M-type phospholipase A2 receptor (PLA2R) in membranous lupus nephritis

Lupus, 2019
Background Antibodies to M-type phospholipase A2 receptor (a-PLA2R) have been identified in most patients with idiopathic membranous nephropathy, but the prevalence in membranous lupus nephritis (MLN) is still unclear.
E. García-Vives   +7 more
semanticscholar   +1 more source

The impact of different classes of lupus nephritis on maternal and fetal outcomes: a cohort study of 147 pregnancies

Lupus, 2019
Objective To analyze the impact of different classes of lupus nephritis as risk variables for maternal and fetal adverse outcomes in a cohort of pregnant lupus patients.
B. Rodrigues   +6 more
semanticscholar   +1 more source

Treatment of lupus nephritis: consensus, evidence and perspectives

Nature Reviews Rheumatology, 2023
C. Mok   +3 more
semanticscholar   +1 more source

Pathogenic cellular and molecular mediators in lupus nephritis

Nature Reviews Nephrology, 2023
C. Mohan, Ting Zhang, C. Putterman
semanticscholar   +1 more source

Pim‐1 as a Therapeutic Target in Lupus Nephritis

Arthritis & Rheumatology, 2019
Lupus nephritis (LN) is a major determinant of morbidity and mortality in systemic lupus erythematosus (SLE). Pim‐1 regulates lymphocyte proliferation and activation. The role of Pim‐1 in autoimmune disease remains unclear.
Rong Fu   +10 more
semanticscholar   +1 more source

Neutrophils in lupus nephritis

Current Opinion in Rheumatology, 2019
Purpose of review Systemic lupus erythematosus (SLE) is a multiorgan autoimmune disease characterized by IgG-autoantibodies to nuclear antigens that can deposit in the kidney and trigger lupus nephritis.
H. Nishi, T. Mayadas
semanticscholar   +1 more source

Lupus nephritis: new progress in diagnosis and treatment.

Journal of Autoimmunity, 2022
Chen Yu   +5 more
semanticscholar   +1 more source

Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis

Lupus, 2018
Animal and human studies have suggested the potential of mesenchymal stromal cells (MSCs) to treat systemic lupus erythematosus (SLE). Here, we present the results of compassionate MSC treatments for three SLE patients to provide the proof of concept for
J. Barbado   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy